-
ECONOMIC EVALUATIONS OF COMPREHENSIVE GENOMIC PROFILING IN ONCOLOGY: A LITERATURE REVIEW AND PRACTICAL GUIDANCE
Aug 11, 2026, 15:45 PM -
COST-EFFECTIVENESS ANALYSIS OF TRIFLURIDINE/TIPIRACIL PLUS BEVACIZUMAB COMBINATION THERAPY AS THIRD-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER IN JAPAN
Aug 11, 2026, 15:45 PM -
FACTORS ASSOCIATED WITH HA GO ADOPTION: A POPULATION-BASED STUDY...
Aug 11, 2026, 15:45 PM -
TRENDS AND BURDEN OF HEART VALVE DISEASE IN KOREA: A NATIONAL CLAIMS DATA ANALYSIS
Aug 11, 2026, 15:45 PM -
HEALTH ECONOMIC EVALUATION OF PROSTATE CANCER RISK CONTROL USING PREIMPLANTATION GENETIC TESTING (PGT-M) FOR BRCA1/2 PATHOLOGICAL VARIANT CARRIERS
Aug 11, 2026, 15:45 PM -
ASSOCIATION BETWEEN TAIWAN ACUTE CARE AT HOME PILOT PROGRAM AND QUALITY OF EMERGENCY CARE...
Aug 11, 2026, 15:45 PM -
PRE-EXTRACTION INTERRUPTION OF BONE-TARGETING AGENTS AND OSTEONECROSIS OF THE JAW IN CANCER PATIENTS WITH BONE METASTASES: A TARGET TRIAL EMULATION WITH DATA-DRIVEN HETEROGENEITY ANALYSIS
Aug 11, 2026, 15:45 PM -
COST-EFFECTIVENESS ANALYSIS OF AXITINIB PLUS AVELUMAB AS FIRST-LINE TREATMENT FOR ADVANCED RENAL CELL CARCINOMA
Aug 11, 2026, 15:45 PM -
SCENARIO-SPECIFIC VALUES OF STATISTICAL LIFE IN JAPAN: EVIDENCE FROM WILLINGNESS-TO-PAY ELICITATION FOR HEALTH, DISASTER, AND SAFETY RISKS
Aug 11, 2026, 15:45 PM -
COST-EFFECTIVENESS ANALYSIS OF TRIFLURIDINE/TIPIRACIL AS THIRD-LINE TREATMENT FOR HEAVILY PRETREATED METASTATIC GASTRIC CANCER IN JAPAN...
Aug 11, 2026, 15:45 PM -
RISING MEDICATION BURDEN IN ADULTS WITH TYPE 1 DIABETES: REAL-WORLD EVIDENCE FROM CHINA
Aug 11, 2026, 15:45 PM -
(PRESTO) PHYSICIAN REASONS FOR SUBCUTANEOUS ANTI-HER2 OPT-IN: FACTORS ASSOCIATED WITH PHYSICIANS’ PREFERENCE IN USING SUBCUTANEOUS FORMULATION OF ANTI-HER2 TREATMENT IN PERSONS WITH BREAST CANCER
Aug 11, 2026, 15:45 PM -
COST-UTILITY ANALYSIS OF LEFT ATRIAL APPENDAGE OCCLUSION VERSUS ANTICOAGULANT THERAPY FOR ATRIAL FIBRILLATION PATIENTS AT HIGH RISK OF STROKE AND MAJOR BLEEDING IN THAILAND...
Aug 11, 2026, 15:45 PM -
A GENAI-BASED VISUALIZATION PLATFORM FOR SYSTEMATIC LITERATURE REVIEW INSIGHTS
Aug 11, 2026, 15:45 PM -
UNIFORM PAYMENT FOR SELECTED DRGS ACROSS HOSPITAL LEVELS: EVIDENCE FROM CHINA’S DRG-BASED PAYMENT REFORM
Aug 11, 2026, 15:45 PM -
AFFORDABILITY OF BIOLOGIC ADD-ON THERAPY FOR SEVERE EOSINOPHILIC ASTHMA IN THAILAND: A BUDGET IMPACT ANALYSIS OF MEPOLIZUMAB AND BENRALIZUMAB...
Aug 11, 2026, 15:45 PM -
PATIENT INVOLVEMENT IN RARE DISEASE HEALTH TECHNOLOGY ASSESSMENT (HTA): REAL-WORLD PRACTICES IN AUSTRALIA, SINGAPORE, AND TAIWAN
Aug 11, 2026, 15:45 PM -
CONSTRUCTION OF A VALUE ASSESSMENT FRAMEWORK FOR NEW ANTIDIABETIC DRUGS TO SUPPORT EVIDENCE-INFORMED DECISION-MAKING
Aug 11, 2026, 15:45 PM -
NMPA NATIONAL REGISTRATION GAPS AND FDA-TO-NMPA APPROVAL LAG AMONG FDA-APPROVED RARE DISEASE THERAPIES: AN INDICATION-LEVEL ANALYSIS OF CHINA’S 207-CONDITION RARE DISEASE CATALOG, 2001-2024
Aug 11, 2026, 15:45 PM -
ASSESSMENT OF THE COST-EFFECTIVENESS OF HOSHINO MUMPS VACCINE AMONG CHILDREN IN INDIA: EVIDENCE FROM A DECISION-TREE MODEL
Aug 11, 2026, 15:45 PM
